On Monday, Delaware’s state investment board approved a $30.2 million grant to Merck & Co., contingent on the company’s decision to set up operations at the Chestnut Run Innovation and Science Park outside the city of Wilmington. The “commercialization and
read moreAs part of a new strategic restructuring to streamline its American operations, Eisai plans to lay off approximately 121 employees across various U.S. functions, a company spokesperson told Fierce Pharma on Thursday. The restructuring will primarily affect commercial, medical and
read more
New partnership to integrate SRD search technology More: Datapharm collaborates with VIDAL to improve medicines information access in France Source: News
read more
New collaboration aims to integrate AI solutions for treatment More: Brainomix partners with Medtronic to enhance stroke care Source: News
read moreWith sales of $103 million in the fourth quarter and $180 million in its first nine months on the market, Madrigal Pharmaceuticals’ metabolic dysfunction-associated steatohepatitis (MASH) treatment Rezdiffra has all the earmarks of a soon-to-be blockbuster. More: Launch metrics of
read moreOn BeiGene’s very first live earnings call, CEO and co-founder John Oyler described a “once-in-a-lifetime opportunity.” To him, the company’s potential in chronic lymphocytic leukemia is akin to two other legendary Big Biotech stories—Gilead in HIV and Vertex in cystic
read more© 1994 - 2025 B.M. Pharmaceuticals